Antibiotic resistances of Clostridium difficile

Patrizia Spigaglia, Paola Mastrantonio, Fabrizio Barbanti

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public health. Antibiotic resistance plays an important role in driving C. difficile epidemiology. Emergence of new types is often associated with the emergence of new resistances and most of epidemic C. difficile clinical isolates is currently resistant to multiple antibiotics. In particular, it is to worth to note the recent identification of strains with reduced susceptibility to the first-line antibiotics for CDI treatment and/or for relapsing infections. Antibiotic resistance in C. difficile has a multifactorial nature. Acquisition of genetic elements and alterations of the antibiotic target sites, as well as other factors, such as variations in the metabolic pathways and biofilm production, contribute to the survival of this pathogen in the presence of antibiotics. Different transfer mechanisms facilitate the spread of mobile elements among C. difficile strains and between C. difficile and other species. Furthermore, recent data indicate that both genetic elements and alterations in the antibiotic targets can be maintained in C. difficile regardless of the burden imposed on fitness, and therefore resistances may persist in C. difficile population in absence of antibiotic selective pressure.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages137-159
Number of pages23
DOIs
Publication statusPublished - Jan 1 2018

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1050
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Clostridium
Clostridium difficile
Microbial Drug Resistance
Anti-Bacterial Agents
Clostridium Infections
Epidemiology
Biofilms
Public health
Pathogens
Metabolic Networks and Pathways
Public Health

Keywords

  • Antibiotic susceptibility methods
  • C. difficile
  • Mechanisms of resistance
  • Multi-drug resistance (MDR)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Spigaglia, P., Mastrantonio, P., & Barbanti, F. (2018). Antibiotic resistances of Clostridium difficile. In Advances in Experimental Medicine and Biology (pp. 137-159). (Advances in Experimental Medicine and Biology; Vol. 1050). Springer New York LLC. https://doi.org/10.1007/978-3-319-72799-8_9

Antibiotic resistances of Clostridium difficile. / Spigaglia, Patrizia; Mastrantonio, Paola; Barbanti, Fabrizio.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. p. 137-159 (Advances in Experimental Medicine and Biology; Vol. 1050).

Research output: Chapter in Book/Report/Conference proceedingChapter

Spigaglia, P, Mastrantonio, P & Barbanti, F 2018, Antibiotic resistances of Clostridium difficile. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1050, Springer New York LLC, pp. 137-159. https://doi.org/10.1007/978-3-319-72799-8_9
Spigaglia P, Mastrantonio P, Barbanti F. Antibiotic resistances of Clostridium difficile. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2018. p. 137-159. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-72799-8_9
Spigaglia, Patrizia ; Mastrantonio, Paola ; Barbanti, Fabrizio. / Antibiotic resistances of Clostridium difficile. Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. pp. 137-159 (Advances in Experimental Medicine and Biology).
@inbook{60dc10f33c084b30aa0d410ae1ae65ca,
title = "Antibiotic resistances of Clostridium difficile",
abstract = "The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public health. Antibiotic resistance plays an important role in driving C. difficile epidemiology. Emergence of new types is often associated with the emergence of new resistances and most of epidemic C. difficile clinical isolates is currently resistant to multiple antibiotics. In particular, it is to worth to note the recent identification of strains with reduced susceptibility to the first-line antibiotics for CDI treatment and/or for relapsing infections. Antibiotic resistance in C. difficile has a multifactorial nature. Acquisition of genetic elements and alterations of the antibiotic target sites, as well as other factors, such as variations in the metabolic pathways and biofilm production, contribute to the survival of this pathogen in the presence of antibiotics. Different transfer mechanisms facilitate the spread of mobile elements among C. difficile strains and between C. difficile and other species. Furthermore, recent data indicate that both genetic elements and alterations in the antibiotic targets can be maintained in C. difficile regardless of the burden imposed on fitness, and therefore resistances may persist in C. difficile population in absence of antibiotic selective pressure.",
keywords = "Antibiotic susceptibility methods, C. difficile, Mechanisms of resistance, Multi-drug resistance (MDR)",
author = "Patrizia Spigaglia and Paola Mastrantonio and Fabrizio Barbanti",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-72799-8_9",
language = "English",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "137--159",
booktitle = "Advances in Experimental Medicine and Biology",
address = "United States",

}

TY - CHAP

T1 - Antibiotic resistances of Clostridium difficile

AU - Spigaglia, Patrizia

AU - Mastrantonio, Paola

AU - Barbanti, Fabrizio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public health. Antibiotic resistance plays an important role in driving C. difficile epidemiology. Emergence of new types is often associated with the emergence of new resistances and most of epidemic C. difficile clinical isolates is currently resistant to multiple antibiotics. In particular, it is to worth to note the recent identification of strains with reduced susceptibility to the first-line antibiotics for CDI treatment and/or for relapsing infections. Antibiotic resistance in C. difficile has a multifactorial nature. Acquisition of genetic elements and alterations of the antibiotic target sites, as well as other factors, such as variations in the metabolic pathways and biofilm production, contribute to the survival of this pathogen in the presence of antibiotics. Different transfer mechanisms facilitate the spread of mobile elements among C. difficile strains and between C. difficile and other species. Furthermore, recent data indicate that both genetic elements and alterations in the antibiotic targets can be maintained in C. difficile regardless of the burden imposed on fitness, and therefore resistances may persist in C. difficile population in absence of antibiotic selective pressure.

AB - The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public health. Antibiotic resistance plays an important role in driving C. difficile epidemiology. Emergence of new types is often associated with the emergence of new resistances and most of epidemic C. difficile clinical isolates is currently resistant to multiple antibiotics. In particular, it is to worth to note the recent identification of strains with reduced susceptibility to the first-line antibiotics for CDI treatment and/or for relapsing infections. Antibiotic resistance in C. difficile has a multifactorial nature. Acquisition of genetic elements and alterations of the antibiotic target sites, as well as other factors, such as variations in the metabolic pathways and biofilm production, contribute to the survival of this pathogen in the presence of antibiotics. Different transfer mechanisms facilitate the spread of mobile elements among C. difficile strains and between C. difficile and other species. Furthermore, recent data indicate that both genetic elements and alterations in the antibiotic targets can be maintained in C. difficile regardless of the burden imposed on fitness, and therefore resistances may persist in C. difficile population in absence of antibiotic selective pressure.

KW - Antibiotic susceptibility methods

KW - C. difficile

KW - Mechanisms of resistance

KW - Multi-drug resistance (MDR)

UR - http://www.scopus.com/inward/record.url?scp=85041617951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041617951&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-72799-8_9

DO - 10.1007/978-3-319-72799-8_9

M3 - Chapter

C2 - 29383668

AN - SCOPUS:85041617951

T3 - Advances in Experimental Medicine and Biology

SP - 137

EP - 159

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -